RARA CRAFT DATABASE for FDA Medical Devices
PMAP170043

FDA DEVICE FACTS

iStent inject Trabecular Micro-Bypass System (Model G2-M-IS)

Glaukos Corporation

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEJune 21, 2018PRODUCT CODEOGO

Indications for use

The iStent inject Trabecular Micro-Bypass System (Model G2-M-IS) is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate primary open-angle glaucoma.

Ill. CONTRAINDICATIONS The iStent inject Trabecular Micro-Bypass System (Model G2-M-IS) (hereafter referred to in this document as iStent inject) is contraindicated under the following circumstances or conditions:

• In eyes with angle closure glaucoma

• In eyes with traumatic, malignant, uveitic, or neovascular glaucoma or discernible congenital anomalies of the anterior chamber (AC) angle

• In patients with retrobulbar tumor, thyroid eye disease, Sturge-Weber Syndrome or any other type of condition that may cause elevated episcleral venous pressure

PMA P170043: FDA Summary of Safety and Effectiveness Page | 2

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026